Medibank Private Crecimiento futuro

Future controles de criterios 1/6

Se prevé que los beneficios de Medibank Private disminuyan en un 1.3% al año, mientras que se espera que sus ingresos anuales crezcan en un 3.5% al año. Se prevé que el BPA disminuya en un 1.6% por año. Se espera que la rentabilidad financiera sea de 24% en 3 años.

Información clave

-1.3%

Tasa de crecimiento de los beneficios

-1.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Insurance	6.1%
Tasa de crecimiento de los ingresos	3.5%
Rentabilidad financiera futura	24.0%
Cobertura de analistas	Good
Última actualización	05 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Here's Why Medibank Private (ASX:MPL) Has Caught The Eye Of Investors

Apr 17

Medibank Private Limited (ASX:MPL) Investors Are Less Pessimistic Than Expected

Feb 03

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

Nov 15

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Nov 01

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 09

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Aug 21

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

May 29

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

Feb 27

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Aug 30

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Feb 14

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Jan 19

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Dec 23

Previsiones de crecimiento de beneficios e ingresos

ASX:MPL - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2026	8,745	600	592	697	6
6/30/2025	8,396	580	596	707	6
6/30/2024	8,097	581	381	699	6
12/31/2023	7,944	685	326	373	N/A
9/30/2023	7,720	598	234	279	N/A
6/30/2023	7,495	511	143	185	N/A
3/31/2023	7,282	395	436	474	N/A
12/31/2022	7,124	343	729	764	N/A
9/30/2022	7,114	368	821	856	N/A
6/30/2022	7,105	394	913	949	N/A
3/31/2022	7,117	414	693	728	N/A
12/31/2021	7,130	435	472	508	N/A
9/30/2021	7,081	438	460	495	N/A
6/30/2021	7,032	441	447	482	N/A
3/31/2021	6,930	402	547	579	N/A
12/31/2020	6,829	363	647	676	N/A
9/30/2020	6,804	340	595	624	N/A
6/30/2020	6,779	316	543	572	N/A
3/31/2020	6,836	368	451	486	N/A
12/31/2019	6,892	420	358	399	N/A
9/30/2019	6,829	429	362	408	N/A
6/30/2019	6,765	438	367	416	N/A
12/31/2018	6,381	375	332	377	N/A
9/30/2018	6,479	400	348	393	N/A
6/30/2018	6,577	424	365	408	N/A
3/31/2018	7,010	454	384	428	N/A
12/31/2017	7,006	463	403	448	N/A
9/30/2017	6,977	456	N/A	421	N/A
6/30/2017	6,948	450	N/A	393	N/A
3/31/2017	6,914	436	N/A	379	N/A
12/31/2016	6,879	422	N/A	365	N/A
9/30/2016	6,843	420	N/A	359	N/A
6/30/2016	6,807	418	N/A	352	N/A
3/31/2016	6,791	393	N/A	363	N/A
12/31/2015	6,774	369	N/A	374	N/A
9/30/2015	6,728	327	N/A	375	N/A
6/30/2015	6,682	285	N/A	377	N/A
3/31/2015	6,631	244	N/A	338	N/A
12/31/2014	6,581	204	N/A	298	N/A
9/30/2014	6,533	167	N/A	306	N/A
6/30/2014	6,486	131	N/A	313	N/A
6/30/2013	6,005	233	N/A	105	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de MPL disminuyan en los próximos 3 años (-1.3% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de MPL disminuyan en los próximos 3 años (-1.3% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de MPL disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.5% al año) de MPL crezcan más despacio que el mercado de Australian (4.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.5% al año) de MPL crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MPL sea alta dentro de 3 años (24%)

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Medibank Private Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates increase by 11%

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Medibank Private Limited Provides Earnings Guidance for 2022

Recent updates

Here's Why Medibank Private (ASX:MPL) Has Caught The Eye Of Investors

High number of new directors

First half dividend increased to AU$0.072

New major risk - Revenue and earnings growth

First half 2024 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Medibank Private Limited (ASX:MPL) Investors Are Less Pessimistic Than Expected

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Now 22% undervalued after recent price drop

Upcoming dividend of AU$0.069 per share

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Medibank Private Limited Provides Earnings Guidance for 2022

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

CEO & Director Craig Drummond has left the company

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Earnings beat expectations, revenue disappoints

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.79

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$3.04

New 90-day high: AU$2.90

New 90-day low - AU$2.49

Independent Non-Executive Director recently bought AU$115k worth of stock

New 90-day low - AU$2.73

Earnings released

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento